Masimo Corp represents a strong commitment to improving patient outcomes and reducing healthcare costs through innovative medical technologies. The company values include a dedication to patient safety, quality, and continuous improvement. Masimo's corporate philosophy revolves around providing noninvasive monitoring solutions that enable clinicians to make more informed decisions, enhance patient care, and optimize workflows. By combining advanced sensor and signal processing technologies, Masimo Corp strives to address the evolving needs of the medical community. The company's focus on research and development, as well as collaboration with healthcare professionals, reinforces its commitment to pioneering advancements in medical monitoring to benefit patients worldwide.

Masimo Corp is primarily present in various countries and regions across the globe. Some notable markets where the company operates include the United States, European countries like Germany, France, and the United Kingdom, as well as Asian countries including Japan and China. Masimo Corp's global presence enables it to provide its innovative healthcare solutions, including noninvasive patient monitoring technologies, to healthcare facilities and professionals worldwide.

Masimo Corp has achieved several significant milestones. Some noteworthy accomplishments include the development of breakthrough technologies in noninvasive patient monitoring, such as SET® pulse oximetry. The company has also received numerous awards and recognition for its innovative products and contributions to the healthcare industry. Masimo Corp has successfully expanded its global presence and formed strategic partnerships with leading healthcare organizations worldwide. Additionally, the company has consistently shown strong financial performance and steady revenue growth over the years. Overall, Masimo Corp continues to make strides in advancing patient care through its cutting-edge technologies and industry leadership.

Masimo Corp is a leading global medical technology company specializing in noninvasive patient monitoring. Founded in 1989 by Joe Kiani, the company has a rich history of innovation and advancements in the healthcare industry. Masimo Corp's core business revolves around developing and manufacturing advanced monitoring technologies, including pulse oximeters and signal extraction technology. With its commitment to improving patient outcomes and reducing healthcare costs, Masimo Corp has revolutionized the way healthcare professionals monitor patients' vital signs. Today, it is recognized as a trusted name in the medical device industry, providing innovative solutions that enhance patient care and safety worldwide.

The main competitors of Masimo Corp in the market include companies such as Philips Healthcare, Nihon Kohden Corporation, and Smiths Medical.

Masimo Corp is primarily active in the medical device industry.

The business model of Masimo Corp focuses on providing innovative noninvasive monitoring technologies. Masimo develops and manufactures a wide range of medical devices and sensors to improve patient outcomes and reduce healthcare costs. The company's flagship product, Masimo SET®, revolutionized pulse oximetry by offering accurate measurements even in challenging conditions. With a dedication to patient safety and care, Masimo Corp combines advanced signal processing and sensor technology to deliver reliable monitoring solutions to healthcare professionals. Through their product portfolio, Masimo Corp aims to enhance patient care and promote efficiency in the healthcare industry.

Masimo의 P/E 비율은 34.04입니다.

Masimo의 P/S 비율은 3.37입니다.

Masimo에 대한 AlleAktien 품질 점수는 5/10입니다.

예상되는 Masimo 매출은 2.14 조. USD입니다.

예상되는 Masimo 이익은 211.69 백만 USD입니다.

Masimo Corporation is a leading provider of medical diagnostic and monitoring technologies that aim to make patient care safer and more effective. The company is headquartered in California and operates offices worldwide. Masimo's business model can be roughly divided into three areas: 1. Products and technologies Masimo offers a wide range of medical devices and technologies, including pulse oximeters for monitoring oxygen saturation in the blood, capnographs for monitoring end-tidal carbon dioxide concentration, as well as patient monitors and control systems. A highlight is Masimo's Signal Extraction Technology (SET), which is used in almost all of the company's products. SET uses a special algorithm to filter signals from skin color, movement, and other external sources of interference, allowing for accurate measurements. Additionally, Masimo has developed other innovative technologies, such as automatic measurement of hemoglobin levels, which can lead to improved patient outcomes. 2. Services Masimo also offers various services, such as installation, training, and technical support for its products. Furthermore, the company has entered into partnerships with other companies such as Apple and Philips to jointly develop innovative solutions for patient monitoring. 3. Research and development Masimo invests heavily in the research and development of new products and technologies. The company has filed numerous patents and successfully implemented them. By collaborating with clinics and universities, Masimo ensures that its products have informative features and high quality that meet the needs of patients and medical professionals. Overall, Masimo's business model is designed to make healthcare safer and more effective by developing innovative products and technologies, and by providing services and support to its customers. The wide range of products and technologies, as well as the investments in research and development, indicate that Masimo will continue to play an important role in the medical industry in the future.

Masimo은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Masimo의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Masimo의 ISIN은 US5747951003입니다.

Masimo의 WKN은 578074입니다.

Masimo의 티커는 MASI입니다.

지난 12개월 동안 Masimo은(는) 1 USD 의 배당금을 지급했습니다. 이는 약 0.75 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Masimo은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Masimo의 현재 배당 수익률은 0.75 %입니다.

Masimo은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Masimo은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Masimo은 '건강' 섹터에 속합니다.

Masimo의 마지막 배당금을 1 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Masimo는 0 USD를 배당금으로 지급했습니다.

Masimo의 배당금은 USD에 지급됩니다.